Regulus Therapeutics | RGLS - Koszty Sprzedaży I Administracji



Koszty Sprzedaży I Administracji Zmiana Data
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Biogen USD 545.2M 38.6M 2025-09
Celldex Therapeutics USD 7.84M 1.21M 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Immunic USD -0.24 0.03 2024-09
Incyte USD 390.41M 61.33M 2025-12
Intrexon USD 10.31M 41K 2024-06
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
Merck USD 2.85B 215M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.75B 455M 2025-12
Takeda JPY 282.78B 29.23B 2025-12